Effects of ambient air pollution on functional status in patients with chronic congestive heart failure: A repeated-measures study

Environmental Health: A Global Access Science Source

Volumn 6, Issue , 2007, Pages

  Wellenius, Gregory A ^a   Yeh, Gloria Y ^a   Coull, Brent A ^b   Suh, Helen H ^b   Phillips, Russell S ^a   Mittleman, Murray A ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CARBON MONOXIDE; NITROGEN DIOXIDE; OZONE; SULFUR DIOXIDE; BIOLOGICAL MARKER;

ADULT; AGED; AIR POLLUTION; AMBIENT AIR; ARTICLE; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DISEASE MARKER; DISEASE SEVERITY; FEMALE; FUNCTIONAL STATUS; HEART HEMODYNAMICS; HUMAN; MALE; MEASUREMENT; RACE DIFFERENCE; REPRODUCIBILITY; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY; SYSTOLIC DYSFUNCTION; AIR POLLUTANT; BLOOD; HEART FAILURE; HEART STROKE VOLUME; LONGITUDINAL STUDY; MIDDLE AGED; PARTICULATE MATTER; PATHOPHYSIOLOGY; PHYSIOLOGY; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; AIR POLLUTANTS; BIOLOGICAL MARKERS; FEMALE; HEART FAILURE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PARTICULATE MATTER; RETROSPECTIVE STUDIES; STROKE VOLUME;

EID: 35248813889     PISSN: None     EISSN: 1476069X     Source Type: Journal    
DOI: 10.1186/1476-069X-6-26     Document Type: Article

References (35)

1. Air pollution and cardiovascular disease: a statement for healthcare professionals from the Expert Panel on Population and Prevention Science of the American Heart Association. RD Brook B Franklin W Cascio Y Hong G Howard M Lipsett R Luepker M Mittleman J Samet SC Smith Jr I Tager, Circulation 2004 109 21 2655 2671 10.1161/01.CIR.0000128587.30041.C8 15173049
2. Air pollution and myocardial infarction in Rome: A case-crossover analysis. D D'Ippoliti F Forastiere C Ancona N Agabiti D Fusco P Michelozzi CA Perucci, Epidemiology 2003 14 5 528 535 10.1097/01.ede.0000082046.22919.72 14501267
3. Increased particulate air pollution and the triggering of myocardial infarction. A Peters DW Dockery JE Muller MA Mittleman, Circulation 2001 103 23 2810 2815 11401937
4. The effect of particulate air pollution on emergency admissions for myocardial infarction: a multicity case-crossover analysis. A Zanobetti J Schwartz, Environ Health Perspect 2005 113 8 978 982 16079066
5. Air pollution and incidence of cardiac arrhythmia. A Peters E Liu RL Verrier J Schwartz DR Gold M Mittleman J Baliff JA Oh G Allen K Monahan DW Dockery, Epidemiology 2000 11 1 11 17 10.1097/00001648-200001000-00005 10615837
6. Association of air pollution with increased incidence of ventricular tachyarrhythmias recorded by implanted cardioverter defibrillators. DW Dockery H Luttmann-Gibson DQ Rich MS Link MA Mittleman DR Gold P Koutrakis JD Schwartz RL Verrier, Environ Health Perspect 2005 113 6 670 674 15929887
7. Association of short-term ambient air pollution concentrations and ventricular arrhythmias. DQ Rich J Schwartz MA Mittleman M Link H Luttmann-Gibson PJ Catalano FE Speizer DW Dockery, Am J Epidemiol 2005 161 12 1123 1132 10.1093/aje/kwi143 15937021
8. Air pollution and hospital admissions for ischemic and hemorrhagic stroke among medicare beneficiaries. GA Wellenius J Schwartz MA Mittleman, Stroke 2005 36 12 2549 2553 10.1161/01.STR.0000189687.78760.47 16254223
9. Evidence for an Association Between Air Pollution and Daily Stroke Admissions in Kaohsiung, Taiwan. SS Tsai WB Goggins HF Chiu CY Yang, Stroke 2003 34 2612 2616 10.1161/01.STR.0000095564.33543.64 14551399
10. Air pollution: a new risk factor in ischemic stroke mortality. YC Hong JT Lee H Kim HJ Kwon, Stroke 2002 33 9 2165 2169 10.1161/01.STR.0000026865.52610. 5B 12215581
11. Particulate air pollution and the rate of hospitalization for congestive heart failure among medicare beneficiaries in Pittsburgh, Pennsylvania. GA Wellenius TF Bateson MA Mittleman J Schwartz, Am J Epidemiol 2005 161 11 1030 1036 15901623 10.1093/aje/kwi135
12. Particulate air pollution and hospital admissions for congestive heart failure in seven United States cities. GA Wellenius J Schwartz MA Mittleman, Am J Cardiol 2006 97 3 404 408 10.1016/j.amjcard.2005.08.061 16442405
13. Air pollution and hospital admissions for cardiovascular disease in Detroit, Michigan. J Schwartz R Morris, Am J Epidemiol 1995 142 1 23 35 7785670
14. Carbon monoxide and hospital admissions for congestive heart failure: evidence of an increased effect at low temperatures. RD Morris EN Naumova, Environ Health Perspect 1998 106 10 649 653 9755140 10.2307/3434092
15. Effects of particulate and gaseous air pollution on cardiorespiratory hospitalizations. RT Burnett M Smith-Doiron D Stieb S Cakmak JR Brook, Arch Environ Health 1999 54 2 130 139 10094292
16. Air pollution and hospital admissions for respiratory and cardiovascular diseases in Hong Kong. TW Wong TS Lau TS Yu A Neller SL Wong W Tam SW Pang, Occup Environ Med 1999 56 10 679 683 10658547
17. Fine particulate air pollution and hospital admission for cardiovascular and respiratory diseases. F Dominici RD Peng ML Bell L Pham A McDermott SL Zeger JM Samet, JAMA 2006 295 10 1127 1134 10.1001/jama.295.10.1127 16522832
18. A daily diary panel study of congestive heart failure: associations between health outcomes and air pollution and weather [Abstract]. MS Goldberg R Burnett N Giannetti NE Mayo K Flegal MF Valois, Epidemiology 2006 17 16 S254 10.1097/00001648-200611001-00656
19. B-type natriuretic peptide in cardiovascular disease. JA de Lemos DK McGuire MH Drazner, Lancet 2003 362 9380 316 322 10.1016/S0140-6736(03)13976-1 12892964
20. A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study. R Kazanegra V Cheng A Garcia P Krishnaswamy N Gardetto P Clopton A Maisel, J Card Fail 2001 7 1 21 29 10.1054/jcaf.2001.23355 11264546
21. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. AS Maisel P Krishnaswamy RM Nowak J McCord JE Hollander P Duc T Omland AB Storrow WT Abraham AH Wu P Clopton PG Steg A Westheim CW Knudsen A Perez R Kazanegra HC Herrmann PA McCullough, N Engl J Med 2002 347 3 161 167 10.1056/NEJMoa020233 12124404
22. A review of the renal and neurohormonal effects of B-type natriuretic peptide. AJ Burger, Congest Heart Fail 2005 11 1 30 38 10.1111/j.1527-5299.2005. 03794.x 15722668
23. The comparative prognostic value of plasma neurohormones at baseline in patients with heart failure enrolled in Val-HeFT. R Latini S Masson I Anand M Salio A Hester D Judd S Barlera AP Maggioni G Tognoni JN Cohn, Eur Heart J 2004 25 4 292 299 10.1016/j.ehj.2003.10.030 14984917
24. Effects of tai chi mind-body movement therapy on functional status and exercise capacity in patients with chronic heart failure: a randomized controlled trial. GY Yeh MJ Wood BH Lorell LW Stevenson DM Eisenberg PM Wayne AL Goldberger RB Davis RS Phillips, Am J Med 2004 117 8 541 548 10.1016/j.amjmed.2004.04.016 15465501
25. Assessing reproducibility by the within-subject coefficient of variation with random effects models. H Quan WJ Shih, Biometrics 1996 52 4 1195 1203 10.2307/2532835 8962450
26. A case-crossover study of fine particulate matter air pollution and onset of congestive heart failure symptom exacerbation leading to hospitalization. JM Symons L Wang E Guallar E Howell F Dominici M Schwab BA Ange J Samet J Ondov D Harrison A Geyh, Am J Epidemiol 2006 164 5 421 433 10.1093/aje/kwj206 16793862
27. Potential role of ultrafine particles in associations between airborne particle mass and cardiovascular health. RJ Delfino C Sioutas S Malik, Environ Health Perspect 2005 113 8 934 946 16079061
28. The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. JL Januzzi Jr CA Camargo S Anwaruddin AL Baggish AA Chen DG Krauser R Tung R Cameron JT Nagurney CU Chae DM Lloyd-Jones DF Brown S Foran-Melanson PM Sluss E Lee-Lewandrowski KB Lewandrowski, Am J Cardiol 2005 95 8 948 954 10.1016/j.amjcard.2004.12.032 15820160
29. Biological variation for N-terminal pro- and B-type natriuretic peptides and implications for therapeutic monitoring of patients with congestive heart failure. AH Wu A Smith S Wieczorek JF Mather B Duncan CM White C McGill D Katten G Heller, Am J Cardiol 2003 92 5 628 631 10.1016/S0002-9149(03)00741-0 12943894
30. High intraindividual variation of B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with stable chronic heart failure. S Bruins MR Fokkema JW Romer MJ Dejongste FP van der Dijs JM van den Ouweland FA Muskiet, Clin Chem 2004 50 11 2052 2058 10.1373/clinchem.2004.038752 15345664
31. The biologic variability of B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide in stable heart failure patients. R O'Hanlon P O'Shea M Ledwidge C O'Loughlin S Lange C Conlon D Phelan S Cunningham K McDonald, J Card Fail 2007 13 1 50 55 10.1016/j.cardfail.2006.09.003 17339003
32. GM Fitzmaurice NM Laird JH Ware, Applied longitudinal analysis Hoboken, N.J.: Wiley-Interscience 2004
33. Effects of valsartan on circulating brain natriuretic peptide and norepinephrine in symptomatic chronic heart failure: the Valsartan Heart Failure Trial (Val-HeFT). R Latini S Masson I Anand D Judd AP Maggioni YT Chiang M Bevilacqua M Salio P Cardano PH Dunselman NJ Holwerda G Tognoni JN Cohn, Circulation 2002 106 19 2454 2458 10.1161/01.CIR.0000036747.68104.AC 12417542
34. Acute effects of smoking on diastolic function in healthy participants: studies by conventional doppler echocardiography and doppler tissue imaging. M Alam BA Samad J Wardell E Andersson C Hoglund R Nordlander, J Am Soc Echocardiogr 2002 15 10 Pt 2 1232 1237 12411910
35. Chronic and acute effects of smoking on left and right ventricular relaxation in young healthy smokers. B Lichodziejewska K Kurnicka K Grudzka J Malysz M Ciurzynski D Liszewska-Pfejfer, Chest 2007 131 4 1142 1148 10.1378/chest.06-2056 17426221